Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-016709-41Phase 4Completed
Phase 4 trial of Fibrinogen human in coagulation defects (2 arms), sponsored by NHS Lothian. Primary endpoint: Pattern of coagulation disturbance. Started Mar 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-016709-41.